10x Genomics is trading at $85.87, up 10.06%, with biotech-sector strength as context; no company-specific catalyst is confirmed. - Search results surfaced no clear announcement explaining the move. - Shares had already risen 6.94% on October 27; a biotech ETF was reported higher during October 28 trading, supporting sector context but not establishing it as the sole cause. - The company’s third-quarter results are scheduled for November 5.